Table 4. Adjusted Associations Between Maternal and Neonatal COVID-19 Diagnosis With Perinatal Morbidity and Mortalitya.
Maternal and neonatal COVID-19 diagnosis | No. (%) | RR (95% CI) | ||
---|---|---|---|---|
SNMIb | SPMMIc | NICU stay ≥7 d | ||
Not-diagnosed mother and neonate | 1462 (66.7) | 1 [Reference] | 1 [Reference] | 1 [Reference] |
Diagnosed mother but neonate not tested | 313 (14.3) | 1.40 (0.72-2.70) | 1.68 (1.20-2.37) | 1.02 (0.60-1.83) |
Diagnosed mother but test-negative neonate | 362 (16.5) | 4.00 (2.29-6.97) | 2.31 (1.69-3.17) | 3.13 (2.10-4.65) |
Diagnosed mother and test-positive neonate | 54 (2.5) | 4.13 (1.69-10.08) | 3.46 (2.13-5.63) | 6.03 (3.35-10.86) |
Abbreviations: NICU, neonatal intensive care unit; RR, relative risk; SNMI, severe neonatal morbidity index; SPMMI, severe perinatal morbidity and mortality index.
Models adjusted for country, month entering study, maternal age, and history of maternal morbidity (including diabetes, thyroid and other endocrine disorders, cardiac disease, hypertension, chronic respiratory disease, kidney disease, malaria, or tuberculosis).
SNMI includes at least 1 of the following morbidities: bronchopulmonary dysplasia, hypoxic-ischemic encephalopathy, sepsis, anemia requiring transfusion, patent ductus arteriosus, intraventricular hemorrhage, necrotizing enterocolitis, or retinopathy of prematurity.
SPMMI includes any of the morbidities listed in the SNMI, intrauterine or neonatal death, or NICU stay ≥7 days.